SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000885590-13-000069
Filing Date
2013-08-09
Accepted
2013-08-09 14:15:59
Documents
2
Period of Report
2013-08-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2098
2 POWER OF ATTORNEY poahassan.txt EX-24 3404
  Complete submission text file 0000885590-13-000069.txt   7191
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017
Business Address
Hassan Fred (Reporting) CIK: 0001110744 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 131025887